Charron, Giselle
Endogenous morphine-like compound immunoreactivity increases in parkinsonism. [electronic resource]
- Brain : a journal of neurology Aug 2011
- 2321-38 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
ISSN: 1460-2156
Standard No.: 10.1093/brain/awr166 doi
Subjects--Topical Terms: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--pharmacology Aged Analysis of Variance Animals Brain--drug effects Choline O-Acetyltransferase--metabolism Chromatography, High Pressure Liquid--methods Dendrites--metabolism Disease Models, Animal Dopamine--metabolism Dopamine Agents--pharmacology Dopamine Plasma Membrane Transport Proteins--deficiency Dopamine and cAMP-Regulated Phosphoprotein 32--metabolism Enzyme Inhibitors--pharmacology Enzyme-Linked Immunosorbent Assay--methods Female Functional Laterality Gene Expression Regulation--drug effects Glial Fibrillary Acidic Protein--metabolism Glutamate Decarboxylase--metabolism Humans Levodopa--pharmacology Macaca fascicularis Male Medial Forebrain Bundle--drug effects Mice Mice, Inbred C57BL Mice, Transgenic Microscopy, Immunoelectron--methods Middle Aged Nerve Growth Factors--metabolism Organic Chemicals--metabolism Oxidopamine--adverse effects Parkinsonian Disorders--chemically induced Postmortem Changes Rats Rats, Sprague-Dawley Receptors, Dopamine D2--metabolism S100 Calcium Binding Protein beta Subunit S100 Proteins--metabolism Tandem Mass Spectrometry alpha-Methyltyrosine--pharmacology